-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, UfRC/JauPeRlDpO86uMEqrMVtXbyJ2/bRhudGPtqdCgZERxyPi3S94ZQX7K5km5I QGRqUWMSJQsJqMgFoT5ROA== 0000897101-06-002634.txt : 20061219 0000897101-06-002634.hdr.sgml : 20061219 20061219170917 ACCESSION NUMBER: 0000897101-06-002634 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20061219 FILED AS OF DATE: 20061219 DATE AS OF CHANGE: 20061219 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: CNS INC /DE/ CENTRAL INDEX KEY: 0000814258 STANDARD INDUSTRIAL CLASSIFICATION: ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS [3845] IRS NUMBER: 411580270 STATE OF INCORPORATION: DE FISCAL YEAR END: 0331 BUSINESS ADDRESS: STREET 1: PO BOX 39802 CITY: MINNEAPOLIS STATE: MN ZIP: 55439 BUSINESS PHONE: 6128206696 MAIL ADDRESS: STREET 1: PO BOX 39802 STREET 2: PO BOX 39802 CITY: MINNEAPOLIS STATE: MN ZIP: 55439 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: KOLLOFSKI LINDA CENTRAL INDEX KEY: 0001243673 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-16612 FILM NUMBER: 061287222 BUSINESS ADDRESS: STREET 1: 2030 WALNUT GROVE LANE CITY: PLYMOUTH STATE: MN ZIP: 55447 4 1 cns064950kollofski_4ex.xml FORM 4 X0202 4 2006-12-19 1 0000814258 CNS INC /DE/ CNXS 0001243673 KOLLOFSKI LINDA 7615 SMETANA LANE EDEN PRAIRIE MN 55344 0 1 0 0 VP, Marketing Common Stock 2006-12-19 4 M 0 50000 5.43 A 50000 D Common Stock 2006-12-19 4 M 0 12057 11.37 A 62057 D Common Stock 2006-12-19 4 M 0 4500 10.06 A 66557 D Common Stock 2006-12-19 4 M 0 5027 15.74 A 71584 D Common Stock 2006-12-19 4 D 0 71584 D 0 D Common Stock 2006-12-19 4 D 0 4000 D 0 I Jointly with Spouse Stock Option (Option to Buy) 5.43 2006-12-19 4 M 0 50000 0 D 2012-10-29 Common Stock 50000 0 D Stock Option (Option to Buy) 11.37 2006-12-19 4 M 0 12057 0 D 2013-10-13 Common Stock 12057 0 D Stock Option (Option to Buy) 10.06 2006-12-19 4 M 0 4500 0 D 2014-06-18 Common Stock 4500 0 D Stock Option (Option to Buy) 15.74 2006-12-19 4 M 0 5027 0 D 2015-04-25 Common Stock 5027 0 D Stock Option (Option to Buy) 11.37 2006-12-19 4 D 0 1443 26.13 D 2013-10-13 Common Stock 1443 0 D Stock Option (Option to Buy) 10.06 2006-12-19 4 D 0 9000 27.44 D 2014-06-18 Common Stock 9000 0 D Stock Option (Option to Buy) 15.74 2006-12-19 4 D 0 9973 21.76 D 2015-04-25 Common Stock 9973 0 D Stock Option (Option to Buy) 21.38 2006-12-19 4 D 0 17604 16.12 D 2016-05-01 Common Stock 17604 0 D Shares disposed of pursuant to an Agreement and Plan of Merger dated as of October 8, 2006 among GlaxoSmithKline plc, Platform Acquisition Corporation and CNS, Inc., as amended, pursuant to which each share of CNS common stock issued and outstanding at the effective time of the merger was converted into the right to receive $37.50 per share in cash, less applicable withholding tax and without interest. At the effective time of the merger pursuant to an Agreement and Plan of Merger dated as of October 8, 2006 among GlaxoSmithKline plc, Platform Acquisition Corporation and CNS, Inc., as amended, all of the CNS stock options outstanding became fully vested. At the effective time of the merger pursuant to an Agreement and Plan of Merger dated as of October 8, 2006 among GlaxoSmithKline plc, Platform Acquisition Corporation and CNS, Inc., as amended, all of the CNS stock options outstanding became fully vested, were cancelled and were converted into the right to receive the excess, if any, of $37.50 over the exercise price of the stock option for each share of CNS common stock subject to the option, less applicable withholding tax and without interest. /s/ By Michael Weber, Attorney-In-Fact 2006-12-19 -----END PRIVACY-ENHANCED MESSAGE-----